The history of molecular magnetism began in 1951 with the study of a dinuclear complex,
copper (II) acetate [B. Bleaney, KD Bowers, Proc. R. Soc. A 214 (1952) 451], however it was …

Two new copper compounds, namely [Cu (3, 5, 6-tcpa) 2 (H 2 O) 4]·[Cu (3, 5, 6-tcpa) 2 (H 2
O) 2](1) and [Cu 2 (3, 5, 6-tcpa) 2 (2, 2′-bipy) 2 (oxa)]· 2EtOH (2)(3, 5, 6-Htcpa= 2-((3, 5, 6 …

Copper (II) complexes with the non-steroidal anti-inflammatory drugs (NSAIDs) naproxen
and diclofenac have been synthesized and characterized in the presence of nitrogen donor …

Copper (II) complexes with the non-steroidal antiinflammatory drug mefenamic acid in the
presence of aqua or nitrogen donor heterocyclic ligands (2, 2′-bipyridine, 1, 10 …

Reaction of Mn (II) with phenoxyalkanoic acids and di-2-pyridyl ketone oxime (Hpko) leads
to neutral tetranuclear complexes of the general formula Mn4 (O)(pko) 4 (phenoxyalkanoato) …

We have synthesized two cobalt (II) 2 and copper (II) 3 complexes of valine-derived Schiff
bases. The obtained complexes were characterized by elemental analysis, FT-IR and X-ray …

We have synthesized and characterized a novel copper (II) complex of the fluoroquinolone
antibacterial drug N-propyl-norfloxacin (Hpr-norf) in the presence of 1, 10-phenanthroline …

Three novel neutral mononuclear copper (II) complexes of the third-generation quinolone
antibacterial drug sparfloxacin in the presence of a nitrogen donor heterocyclic ligand 2, 2 …

The mononuclear copper complexes with the quinolone antibacterial drug enrofloxacin (=
Herx) in the presence or not of a nitrogen donor heterocyclic ligand 1, 10-phenanthroline …

The copper complexes with the phenoxyalkanoic acids MCPA, 2, 4-D, 2, 4, 5-T and 2, 4-DP
in the presence of a nitrogen donor heterocyclic ligand, phen or bipyam, were prepared and …